Sinovac Biotech, Ltd
SVA
SVA was delisted on the 22nd of February, 2019.
40 hedge funds and large institutions have $62.6M invested in Sinovac Biotech, Ltd in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 9 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 12
7% less funds holding
Funds holding: 43 → 40 (-3)
7% less capital invested
Capital invested by funds: $67.3M → $62.6M (-$4.77M)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
98% less call options, than puts
Call options by funds: $2K | Put options by funds: $80K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$894K |
| 2 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
+$886K |
| 3 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$272K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$211K |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$129K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$1.6M |
| 2 |
O
OrbiMed
New York
|
-$759K |
| 3 |
SI
Sensato Investors
San Francisco,
California
|
-$396K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$234K |
| 5 |
Two Sigma Investments
New York
|
-$212K |
SVA Hedge Fund Activity: Q1 2015 in Review
40 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q1 2015, worth a combined $62.6M — down 7.1% from $67.3M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of SVA and 6 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 12 added.
The largest buyer was Wellington Management Group, adding an estimated $894K. The largest seller was Pictet Asset Management (UK), exiting entirely with an estimated $1.6M sold.
- 40 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q1 2015, down from 43 in Q4 2014.
- Funds reported $62.6M of Sinovac Biotech, Ltd stock for Q1 2015, down 7.1% quarter-over-quarter.
- 6 funds opened new Sinovac Biotech, Ltd positions in Q1 2015 and 9 closed out, a net change of -3 holders.
- The largest Sinovac Biotech, Ltd buyer in Q1 2015 was Wellington Management Group, an estimated $894K added.
- The largest Sinovac Biotech, Ltd seller in Q1 2015 was Pictet Asset Management (UK), an estimated $1.6M sold.
Based on aggregated 13F filings for Q1 2015.